LAMP2 and Alzheimer disease: Brain tissue of patients with AD also exhibited intraneuronal and global elevation of Aβ, CHMP2B and galectin-3 immunoreactivity co-localized with LAMP2 compared with healthy control (HC) individuals (Fig. 4c and Extended Data Fig. 10a–d).